The sterile iv containers market size has grown rapidly in recent years. It will grow from $6.36 billion in 2025 to $7.06 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to hospital admissions growth, intravenous therapy usage, infection control standards, pharmaceutical demand, emergency care expansion.
The sterile iv containers market size is expected to see rapid growth in the next few years. It will grow to $10.61 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to ambulatory care growth, sustainability initiatives, iv drug administration demand, chronic disease treatment, healthcare infrastructure expansion. Major trends in the forecast period include rising demand for non pvc iv containers, growth of pre filled iv solutions, increased focus on infection prevention, expansion of hospital and clinic infrastructure, adoption of customizable iv packaging.
The increasing adoption of home healthcare is increasingly supporting the expansion of the sterile IV containers market going forward. Home healthcare involves delivering medical and personal care services in patients’ homes, allowing treatment outside traditional healthcare facilities. The growing adoption of home healthcare is driven by an aging population and the rising need for long-term intravenous therapies and chronic disease management at home. Sterile IV containers are essential in home healthcare settings to ensure safe, contamination-free delivery of intravenous treatments. For example, in December 2024, according to the Centers for Medicare and Medicaid Services, spending on freestanding home healthcare services increased by 10.8% in 2023 to $147.8 billion. As a result, the expanding adoption of home healthcare is strengthening demand for sterile IV containers.
Leading companies operating in the sterile IV container market are focusing on developing advanced drug delivery systems, such as pre-mixed solutions in duplex containers, to improve efficiency, enhance medication safety, and reduce manual compounding errors and contamination risks. Pre-mixed solutions in duplex containers are integrated drug delivery systems in which medication and diluent are stored separately until activation, allowing immediate intravenous administration. For example, in March 2025, B. Braun Medical Inc., a US-based medical device company, launched Ready-to-Activate Cefazolin 3 gram pre-mix in Duplex containers. The dual-chamber system keeps the drug powder and diluent separated until use and enables quick activation by manipulating the container, eliminating complex reconstitution steps and reducing contamination and dosing errors.
In November 2024, ICU Medical Inc., a US-based medical device company, and Otsuka Pharmaceutical Factory Inc. established a joint venture to enhance IV solution manufacturing and innovation in North America. This joint venture combines ICU Medical’s expertise in infusion devices with Otsuka’s pharmaceutical manufacturing capabilities to increase IV solution production and improve patient care outcomes. Otsuka Pharmaceutical Factory Inc. is a Japan-based pharmaceutical company specializing in sterile IV containers and injectable drug solutions.
Major companies operating in the sterile iv containers market are Cardinal Health Inc., Fresenius Kabi, Medline Industries Inc., Becton Dickinson and Company BD, Baxter International Inc., B Braun SE, Terumo Medical Corporation, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Amsino International Inc., Technoflex, MedicoPack, JW Life Science Corp, SSY Group Limited, Vioser SA, Polycine GmbH, Grifols SA, EuroLife Healthcare Pvt Ltd, Huaren Pharmaceutical Co Ltd, Sichuan Kelun Pharmaceutical Co Ltd, IVEN Pharmatech, Nephron Pharmaceuticals.
North America was the largest region in the sterile IV containers market in 2025. The regions covered in the sterile iv containers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sterile iv containers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased costs of plastic resins and packaging materials, impacting flexible IV bags and pour bottles, particularly in Asia-Pacific. Hospitals face procurement cost increases, while manufacturers benefit from incentives to localize production and develop alternative materials.
The sterile iv containers market research report is one of a series of new reports that provides sterile iv containers market statistics, including sterile iv containers industry global market size, regional shares, competitors with a sterile iv containers market share, detailed sterile iv containers market segments, market trends and opportunities, and any further data you may need to thrive in the sterile iv containers industry. This sterile iv containers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Sterile intravenous (IV) containers are medical-grade containers used to store IV fluids and medications administered directly into a patient’s bloodstream. They are sterilized to ensure they remain free of harmful microorganisms or contaminants that could cause infection when infused into the body.
The main types of sterile intravenous (IV) containers include pour bottles and flexible bags. Pour bottles are rigid, sterile IV containers designed to allow controlled dispensing of fluids, making them suitable for hospital and clinical use where accurate fluid administration is required. These containers are manufactured using materials such as non-polyvinyl chloride (PVC) and polyvinyl chloride (PVC) and are used across applications including hospitals, clinics, ambulatory care centers, and others.
The sterile IV containers market consists of sales of sterile intravenous (IV) bags, pre-filled containers, y-site connectors, and needle-free valves. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The sterile iv containers market size is expected to see rapid growth in the next few years. It will grow to $10.61 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to ambulatory care growth, sustainability initiatives, iv drug administration demand, chronic disease treatment, healthcare infrastructure expansion. Major trends in the forecast period include rising demand for non pvc iv containers, growth of pre filled iv solutions, increased focus on infection prevention, expansion of hospital and clinic infrastructure, adoption of customizable iv packaging.
The increasing adoption of home healthcare is increasingly supporting the expansion of the sterile IV containers market going forward. Home healthcare involves delivering medical and personal care services in patients’ homes, allowing treatment outside traditional healthcare facilities. The growing adoption of home healthcare is driven by an aging population and the rising need for long-term intravenous therapies and chronic disease management at home. Sterile IV containers are essential in home healthcare settings to ensure safe, contamination-free delivery of intravenous treatments. For example, in December 2024, according to the Centers for Medicare and Medicaid Services, spending on freestanding home healthcare services increased by 10.8% in 2023 to $147.8 billion. As a result, the expanding adoption of home healthcare is strengthening demand for sterile IV containers.
Leading companies operating in the sterile IV container market are focusing on developing advanced drug delivery systems, such as pre-mixed solutions in duplex containers, to improve efficiency, enhance medication safety, and reduce manual compounding errors and contamination risks. Pre-mixed solutions in duplex containers are integrated drug delivery systems in which medication and diluent are stored separately until activation, allowing immediate intravenous administration. For example, in March 2025, B. Braun Medical Inc., a US-based medical device company, launched Ready-to-Activate Cefazolin 3 gram pre-mix in Duplex containers. The dual-chamber system keeps the drug powder and diluent separated until use and enables quick activation by manipulating the container, eliminating complex reconstitution steps and reducing contamination and dosing errors.
In November 2024, ICU Medical Inc., a US-based medical device company, and Otsuka Pharmaceutical Factory Inc. established a joint venture to enhance IV solution manufacturing and innovation in North America. This joint venture combines ICU Medical’s expertise in infusion devices with Otsuka’s pharmaceutical manufacturing capabilities to increase IV solution production and improve patient care outcomes. Otsuka Pharmaceutical Factory Inc. is a Japan-based pharmaceutical company specializing in sterile IV containers and injectable drug solutions.
Major companies operating in the sterile iv containers market are Cardinal Health Inc., Fresenius Kabi, Medline Industries Inc., Becton Dickinson and Company BD, Baxter International Inc., B Braun SE, Terumo Medical Corporation, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Amsino International Inc., Technoflex, MedicoPack, JW Life Science Corp, SSY Group Limited, Vioser SA, Polycine GmbH, Grifols SA, EuroLife Healthcare Pvt Ltd, Huaren Pharmaceutical Co Ltd, Sichuan Kelun Pharmaceutical Co Ltd, IVEN Pharmatech, Nephron Pharmaceuticals.
North America was the largest region in the sterile IV containers market in 2025. The regions covered in the sterile iv containers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sterile iv containers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased costs of plastic resins and packaging materials, impacting flexible IV bags and pour bottles, particularly in Asia-Pacific. Hospitals face procurement cost increases, while manufacturers benefit from incentives to localize production and develop alternative materials.
The sterile iv containers market research report is one of a series of new reports that provides sterile iv containers market statistics, including sterile iv containers industry global market size, regional shares, competitors with a sterile iv containers market share, detailed sterile iv containers market segments, market trends and opportunities, and any further data you may need to thrive in the sterile iv containers industry. This sterile iv containers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Sterile intravenous (IV) containers are medical-grade containers used to store IV fluids and medications administered directly into a patient’s bloodstream. They are sterilized to ensure they remain free of harmful microorganisms or contaminants that could cause infection when infused into the body.
The main types of sterile intravenous (IV) containers include pour bottles and flexible bags. Pour bottles are rigid, sterile IV containers designed to allow controlled dispensing of fluids, making them suitable for hospital and clinical use where accurate fluid administration is required. These containers are manufactured using materials such as non-polyvinyl chloride (PVC) and polyvinyl chloride (PVC) and are used across applications including hospitals, clinics, ambulatory care centers, and others.
The sterile IV containers market consists of sales of sterile intravenous (IV) bags, pre-filled containers, y-site connectors, and needle-free valves. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Sterile IV Containers Market Characteristics
3. Sterile IV Containers Market Supply Chain Analysis
4. Global Sterile IV Containers Market Trends and Strategies
5. Sterile IV Containers Market Analysis of End Use Industries
7. Global Sterile IV Containers Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Sterile IV Containers Total Addressable Market (TAM) Analysis for the Market
9. Sterile IV Containers Market Segmentation
10. Sterile IV Containers Market Regional and Country Analysis
11. Asia-Pacific Sterile IV Containers Market
12. China Sterile IV Containers Market
13. India Sterile IV Containers Market
14. Japan Sterile IV Containers Market
15. Australia Sterile IV Containers Market
16. Indonesia Sterile IV Containers Market
17. South Korea Sterile IV Containers Market
18. Taiwan Sterile IV Containers Market
19. South East Asia Sterile IV Containers Market
20. Western Europe Sterile IV Containers Market
21. UK Sterile IV Containers Market
22. Germany Sterile IV Containers Market
23. France Sterile IV Containers Market
24. Italy Sterile IV Containers Market
25. Spain Sterile IV Containers Market
26. Eastern Europe Sterile IV Containers Market
27. Russia Sterile IV Containers Market
28. North America Sterile IV Containers Market
29. USA Sterile IV Containers Market
30. Canada Sterile IV Containers Market
31. South America Sterile IV Containers Market
32. Brazil Sterile IV Containers Market
33. Middle East Sterile IV Containers Market
34. Africa Sterile IV Containers Market
36. Sterile IV Containers Market Competitive Landscape and Company Profiles
37. Sterile IV Containers Market Other Major and Innovative Companies
40. Sterile IV Containers Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Sterile IV Containers Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses sterile iv containers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for sterile iv containers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sterile iv containers market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Pour Bottles; Flexible Bags2) By Material: Non-Polyvinyl Chloride (PVC); Polyvinyl Chloride (PVC)
3) By Application: Hospital; Clinic; Ambulatory Care Centers; Other Applications
Subsegments:
1) By Pour Bottles: Glass Pour Bottles; Plastic Pour Bottles; Single-Dose Pour Bottles; Multi-Dose Pour Bottles2) By Flexible Bags: Polyvinyl Chloride (PVC) Bags; Polyolefin Bags; Non-PVC Flexible Bags; Customizable IV Bags For Specific Solutions; Pre-Filled Flexible Bags
Companies Mentioned: Cardinal Health Inc.; Fresenius Kabi; Medline Industries Inc.; Becton Dickinson and Company BD; Baxter International Inc.; B Braun SE; Terumo Medical Corporation; Nipro Corporation; West Pharmaceutical Services Inc.; ICU Medical Inc.; Amsino International Inc.; Technoflex; MedicoPack; JW Life Science Corp; SSY Group Limited; Vioser SA; Polycine GmbH; Grifols SA; EuroLife Healthcare Pvt Ltd; Huaren Pharmaceutical Co Ltd; Sichuan Kelun Pharmaceutical Co Ltd; IVEN Pharmatech; Nephron Pharmaceuticals
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Sterile IV Containers market report include:- Cardinal Health Inc.
- Fresenius Kabi
- Medline Industries Inc.
- Becton Dickinson and Company BD
- Baxter International Inc.
- B Braun SE
- Terumo Medical Corporation
- Nipro Corporation
- West Pharmaceutical Services Inc.
- ICU Medical Inc.
- Amsino International Inc.
- Technoflex
- MedicoPack
- JW Life Science Corp
- SSY Group Limited
- Vioser SA
- Polycine GmbH
- Grifols SA
- EuroLife Healthcare Pvt Ltd
- Huaren Pharmaceutical Co Ltd
- Sichuan Kelun Pharmaceutical Co Ltd
- IVEN Pharmatech
- Nephron Pharmaceuticals
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 7.06 Billion |
| Forecasted Market Value ( USD | $ 10.61 Billion |
| Compound Annual Growth Rate | 10.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
